Works by Liu, Xuyi


Results: 26
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2012, v. 8, n. 3, p. 232, doi. 10.1111/j.1743-7563.2012.01518.x
    By:
    • WU, Yi-Long;
    • CHU, Da-Tong;
    • HAN, Baohui;
    • LIU, Xuyi;
    • ZHANG, Li;
    • ZHOU, Caicum;
    • LIAO, Meilin;
    • MOK, Tony;
    • JIANG, Haiyi;
    • DUFFIELD, Emma;
    • FUKUOKA, Masahiro
    Publication type:
    Article
    23
    24
    25
    26